GUERBET (GBT.PA) Stock Price, Forecast & Analysis
Europe • Euronext Paris • EPA:GBT • FR0000032526
GBT.PA Key Statistics, Chart & Performance
The current stock price of GBT.PA is 13.73 EUR. In the past month the price decreased by -7.23%. In the past year, price decreased by -47.19%.
GBT.PA Technical Analysis
GBT.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to GBT.PA. While GBT.PA seems to be doing ok healthwise, there are quite some concerns on its profitability.
GBT.PA Financial Highlights
Over the last trailing twelve months GBT.PA reported a non-GAAP Earnings per Share(EPS) of 0.6. The EPS decreased by -77.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.96% | ||
| ROA | 0.76% | ||
| ROE | 2.06% | ||
| Debt/Equity | 0.93 |
GBT.PA Forecast & Estimates
10 analysts have analysed GBT.PA and the average price target is 13.26 EUR. This implies a price decrease of -3.42% is expected in the next year compared to the current price of 13.73.
For the next year, analysts expect an EPS growth of -96.34% and a revenue growth -4.68% for GBT.PA
GBT.PA Ownership
GBT.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ESL | ESSILORLUXOTTICA | 31.85 | 118.566B | ||
| EL | ESSILORLUXOTTICA | 32.42 | 118.52B | ||
| 1EL | ESSILORLUXOTTICA | 31.82 | 118.474B | ||
| AFME | AFFLUENT MEDICAL SA | N/A | 110.574M | ||
| ALCJ | CROSSJECT | 5.64 | 103.88M | ||
| SVS | SVAS BIOSANA SPA | 5.83 | 48.16M | ||
| PTP | PENTIXAPHARM HOLDING AG | N/A | 46.624M | ||
| IVN | IVISION TECH SPA | N/A | 18.826M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About GBT.PA
Company Profile
Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company is headquartered in Villepinte, Ile-De-France and currently employs 2,905 full-time employees. The company produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The firm operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.
Company Info
GUERBET
15 rue des Vanesses, Zone Paris Nord II
Villepinte ILE-DE-FRANCE FR
Employees: 2842
Phone: 33145915000
GUERBET / GBT.PA FAQ
What does GBT do?
Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company is headquartered in Villepinte, Ile-De-France and currently employs 2,905 full-time employees. The company produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The firm operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.
What is the stock price of GUERBET today?
The current stock price of GBT.PA is 13.73 EUR. The price decreased by -0.22% in the last trading session.
Does GUERBET pay dividends?
GUERBET (GBT.PA) has a dividend yield of 2.69%. The yearly dividend amount is currently 0.5.
How is the ChartMill rating for GUERBET?
GBT.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the market expecting GBT stock to perform?
10 analysts have analysed GBT.PA and the average price target is 13.26 EUR. This implies a price decrease of -3.42% is expected in the next year compared to the current price of 13.73.
What is the employee count for GBT stock?
GUERBET (GBT.PA) currently has 2842 employees.
Can you provide the upcoming earnings date for GUERBET?
GUERBET (GBT.PA) will report earnings on 2026-02-05.